| Starting this week, we'll be sending the Coronavirus Update three times a week instead of every day, with a more in-depth report on Fridays. Keep an eye out for our next dispatch on Wednesday. A century-old TB shot could protect against Covid-19, Russia sells its vaccine to more than 10 countries, and the common cold strains testing and supplies. Here's what you should know: Headlines A century-old TB vaccine shows some promise for fending off Covid-19 Research has found that an old tuberculosis vaccine for newborns protected people over 65 against viral respiratory infections. Some scientists say this suggests that the shot creates a "trained" innate immune response that rewires the immune system to ward off multiple diseases. Now there's hope that this vaccine could also protect against Covid-19, and there are at least 20 randomized clinical trials underway. Russia sells its controversial Covid-19 vaccine to more than 10 countries Russia has struck deals to sell its Covid-19 vaccine to more than 10 countries including Brazil, Saudi Arabia, and India, and is in talks with roughly 10 other countries. The shot was approved by Russian authorities in August after small-scale tests on just 76 volunteers had been completed. It began trials on 40,000 volunteers late last month. It will be manufactured and distributed as soon as November, though it will require local regulatory approval before distribution. The return of the common cold puts a strain on Covid-19 testing and supplies During lockdowns this spring, the winter flu was a nonevent in the southern hemisphere, and the common cold effectively vanished. But now non-Covid respiratory illnesses are making a comeback, even with social distancing and mask rules still in place. And dealing with all of them is already hampering Covid-19 efforts and putting a strain on supplies. Daily Distraction Fourteen years after she published her 846-page long debut, Jonathan Strange & Mr. Norrell, fantasy writer Susanna Clarke is back with her long-awaited sophomore novel. Something to Read For those of us able to work from home, this pandemic has totally collapsed the work-life divide. But really, work and life have been bleeding into each other for a long time—thanks in large part to technology. Sanity Check It can be hard to get grown ups to keep their masks on, let alone kids. Here are a few child-friendly face coverings that might do the trick. One Question What are the symptoms of Covid-19? The most common symptoms of Covid-19 are dry cough, fever, and shortness of breath. Others include diarrhea and loss of smell or taste. Some people develop severe blood clots. The disease is mercurial—fairly mild for some and fatal for others. Scientists can't say definitively why, but women are less likely to die than men. We know that older people, especially those with underlying health issues, are more at risk. And children fare better than adults, but for babies, toddlers, and kids with other conditions the disease can be severe. Covid-19 Care Package ❓ From social distancing to viral spread to staying sane, here's everything we know and advise about the coronavirus. 📦 The Covid-19 virus can linger on objects for as little as a few hours or as long as a couple of days, depending on the surface. Here's the research. 😷 If you're planning to go out in public anytime soon, you're going to need a mask. Here are the best ones you can buy, or how to make one at home. 🧼 It's not just your hands that need washing—your gadgets, clothes, and home need it too. Here's how to properly disinfect your stuff. 💻 Some of you are work-from-home pros, but if you're new to it, here's how to stay productive without losing your mind. 😔 It's hard not to be anxious about a global pandemic, but here's how you can protect yourself and your family without spiraling, and how to not hate the loved ones you're quarantined with. ✂️ It may still be a while before you can see your hairstylist, so here's how to cut your hair at home, plus other ways to keep yourself lookin' fresh. 🦠 Read all of our coronavirus coverage here. | 
0 Comments:
Post a Comment